Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

NICE publishes new guidance on managing Lyme disease

NICE has published a new guideline (NG95) on the diagnosis and management of Lyme disease. The aim is to raise awareness of the symptoms of the disease and to...Read more

Anticholinergic medicines may increase dementia risk

Some classes of anticholinergic drug can increase the risk of future dementia, suggests a recent study published in the BMJ (2018;361:k1315). The case-control...Read more

Many online GP services still unsafe, says CQC

According to a recent report from the Care Quality Commission (CQC), the quality of online services that provide GP consultations through independent websites...Read more

NICE publishes guidance on antimicrobial prescribing for otitis media

NICE has published a new guideline on the treatment of acute otitis media (NG91) in children and young people under the age of 18 years. The guideline,...Read more

Over 200m medication errors in England every year

A mistake is made for every five NHS medications given to patients in England, according to a recent report from the Policy Research Unit in Economic...Read more

Featured Articles

BAP consensus guidelines on autism spectrum disorder
The British Association for Psychopharmacology recently issued new guidelines on the assessment and treatment of autism spectrum disorder, based on consensus rather than systematic review. This article provides an overview of the main recommendations.
Click here to view

Management of benign vulval dermatoses in primary care
Vulval dermatoses can be difficult to manage in primary care, and GPs need to be aware of the risk of malignancy. This article describes the most common types of benign vulval dermatoses encountered in primary care and their management, and discusses when referral to secondary care is required.
Click here to view

Is weight loss the future of type 2 diabetes treatment?
Achieving remission from type 2 diabetes was once only thought to be realistic for patients undergoing bariatric surgery. But this view is changing with early publication of results from the Diabetes Remission Clinical Trial, which has found success through a strict low-calorie diet. This article discusses the implications of the study for the future of diabetes treatment.
Click here to view

Web design and marketing agency Leamington Spa